RALGAPA1
protein-codingRal GTPase activating protein catalytic subunit alpha 1
Gene summary
This gene encodes a major subunit of the RAL-GTPase activating protein. A similar protein in mouse binds E12, a transcriptional regulator of immunoglobulin genes. The mouse protein also functions in skeletal muscle by binding to the regulatory 14-3-3 proteins upon stimulation with insulin or muscle contraction. A pseudogene of this gene has been identified on chromosome 9. [provided by RefSeq, Oct 2016]
- GARNL1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~271.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032921
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032921
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032921
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032921
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Pulmonary
Intervention: Pulmonary
Rationale: Among other findings, individuals have been described with neonatal respiratory insufficiency requiring intervention, and awareness may allow such interventions to be performed efficiently
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RALGAPA1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001346249.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 40 | 1 | 43 | ||
| missense | 1 | 243 | 13 | 2 | 259 | |
| nonsense | 4 | 2 | 2 | 8 | ||
| start loss | 0 | |||||
| frameshift | 3 | 3 | 2 | 8 | ||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 8 | 6 | 251 | 53 | 3 | 321 |
Highest pathogenic variant AF is 0.000003246163
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001333178.1 | 41 | MANE Select | |
| Ensembl | ENSP00000506280.1 | 41 | MANE Select | |
| RefSeq | NP_001269972.1 | 41 | Standard | |
| RefSeq | NP_001269973.1 | 41 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ralgapa1 | Danio rerio | Structure: head Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Integrated Breast Cancer Pathway
Biological Process
- regulation of small GTPase mediated signal transduction
- activation of GTPase activity
Molecular Function
- GTPase activator activity
- protein heterodimerization activity
Cellular Component
- nucleus
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000307138
- Coding exons
- 40
- Length
- 270953
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 21
- Defined
- 125748
- p
- 0.0000835
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.53 | 716 | 1.04e+3 | 0.692 | 0.0000518 | 13697 |
| Missense (PolyPhen) | 327 | 551.23 | 0.59322 | 7324 | ||
| Synonymous | 0.767 | 330 | 348 | 0.948 | 0.0000174 | 3922 |
| Loss of Function | 8.03 | 16 | 105 | 0.153 | 0.00000583 | 1297 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000063 | 0.000062 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.000082 | 0.000079 | rare |
| South Asian | 0.000067 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalytic subunit of the heterodimeric RalGAP1 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- LoFtool
- 0.0300
- RVIS EVS
- -1.21
- RVIS percentile EVS
- 5.71
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.969
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |